Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HUYNH TRUONG PHAM VU MD LTD

NPI: 1942497292 · HENDERSON, NV 89052 · Pediatrics Physician · NPI assigned 10/01/2007

$1.48M
Total Medicaid Paid
39,293
Total Claims
35,560
Beneficiaries
51
Codes Billed
2018-02
First Month
2024-11
Last Month

Provider Details

Authorized OfficialVU, HUYNH TRUONG (PRESIDENT)
NPI Enumeration Date10/01/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 301 $14K
2019 8,228 $318K
2020 6,672 $237K
2021 7,986 $301K
2022 6,642 $240K
2023 6,587 $249K
2024 2,877 $119K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10,239 8,949 $561K
90460 Immunization administration through 18 years of age via any route, first or only component 6,761 6,298 $232K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,649 2,367 $198K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,274 2,148 $186K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,106 1,009 $86K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 787 746 $66K
99070 3,644 3,327 $44K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 561 449 $30K
90461 625 585 $20K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 158 148 $14K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 412 374 $10K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 463 423 $6K
90680 712 668 $6K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 32 29 $3K
90670 1,404 1,320 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 349 250 $2K
87301 296 273 $2K
99383 13 13 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 81 78 $2K
99384 15 14 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 175 166 $1K
87807 276 238 $1K
90686 412 392 $841.20
90685 186 175 $616.84
96110 Developmental screening, with scoring and documentation, per standardized instrument 102 94 $600.61
36416 194 167 $498.63
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 20 13 $447.09
96127 91 82 $372.62
90647 153 145 $271.63
88720 98 67 $220.42
94760 123 106 $214.41
90698 504 474 $133.32
90710 125 118 $133.32
90672 91 83 $111.11
99000 2,899 2,595 $1.58
90677 32 31 $0.15
91307 24 16 $0.06
90671 68 66 $0.04
90651 43 39 $0.03
90744 87 81 $0.00
90660 12 12 $0.00
90723 13 13 $0.00
90697 42 41 $0.00
90619 40 37 $0.00
90696 46 41 $0.00
90633 562 528 $0.00
99173 80 77 $0.00
90707 15 12 $0.00
99072 143 127 $0.00
90715 30 30 $0.00
90734 26 26 $0.00